sever
acut
respiratori
syndrom
sar
emerg
infecti
diseas
caus
highli
contagi
coronaviru
sarscov
transmit
direct
indirect
contact
secret
mucou
membran
diseas
first
appear
southern
china
late
rapidli
spread
countri
within
first
month
end
epidem
world
health
organ
estim
number
probabl
sar
case
death
sinc
initi
epidem
declar
juli
sever
new
laboratori
confirm
case
sar
late
result
accident
research
laboratori
exposur
singapor
taiwan
china
anim
environment
exposur
china
recent
center
diseas
control
prevent
cdc
guidelin
clinic
specimen
collect
diagnost
test
interpret
algorithm
sarscov
infect
develop
accord
guidelin
respiratori
tract
blood
stool
prefer
specimen
serolog
molecular
diagnost
test
clinic
cours
diseas
sever
enzym
immunoassay
immunofluoresc
assay
serolog
diagnosi
reversetranscriptas
pcr
rtpcr
assay
detect
sarscov
rna
clinic
specimen
describ
bayer
astound
research
accomplish
fulllength
genom
sequenc
sarscov
avail
within
week
identif
pathogen
initi
global
alert
avail
nucleotid
sequenc
allow
develop
specif
molecular
diagnost
assay
detect
sarscov
rna
clinic
specimen
bayer
healthcar
diagnost
develop
onestep
realtim
quantit
rtpcr
assay
sarscov
rna
quantif
full
genom
sequenc
sarscov
use
design
homolog
forward
revers
primer
fluoresc
label
taqman
probe
target
pair
nucleocapsid
genom
region
primer
probe
design
includ
blast
search
human
coronavirus
human
genom
dna
exclud
sequenc
cross
reactiv
second
heterolog
amplif
system
includ
forward
revers
primer
fluoresc
label
taqman
probe
target
includ
intern
control
assay
process
includ
sampl
prepar
pcr
amplif
onestep
amplif
reaction
perform
use
qiagen
onestep
rtpcr
kit
qiagen
valencia
ca
usa
reaction
volum
contain
target
extract
patient
tissu
rna
heterolog
intern
control
rna
reaction
first
incub
min
complet
revers
transcriptas
step
follow
incub
min
inactiv
rt
enzym
reaction
thermocycl
follow
paramet
denatur
sec
follow
cycl
sec
sec
stratagen
tm
realtim
pcr
system
stratagen
la
jolla
ca
usa
use
analyz
emit
fluoresc
amplif
posit
neg
control
contain
standard
sar
viral
cultur
rna
extract
cell
cultur
supernat
cell
nation
center
infecti
diseas
cdc
atlanta
ga
usa
nucleasefre
rna
diluent
respect
includ
run
extern
standard
sarscov
rna
quantif
prepar
serial
dilut
quantifi
sarscov
rna
cultur
extract
concentr
rang
reaction
quantif
standard
valu
assign
comparison
three
lot
purifi
rna
transcript
gener
nucleocapsid
region
clone
plasmid
plasmid
provid
materi
transfer
agreement
cdc
rna
transcript
prepar
promot
use
megascript
tm
vitro
transcript
kit
ambion
austin
tx
usa
concentr
transcript
determin
measur
absorb
nm
quantifi
viral
rna
standard
treat
purifi
sampl
test
volum
amplif
reaction
use
calcul
sarscov
viral
load
clinic
specimen
realart
tm
hpacoronaviru
lightcycl
rt
reagent
assay
artu
gmbh
hamburg
germani
lightcycl
realtim
pcr
instrument
roch
diagnost
laval
canada
perform
accord
manufactur
instruct
viral
load
calcul
standard
curv
base
four
extern
posit
control
rang
includ
assay
kit
assay
perform
defin
user
manual
provid
realart
tm
hpacoronaviru
lc
rt
pcr
kit
artu
perform
bayer
healthcar
diagnost
researchbas
sarsassoci
coronaviru
assay
bayer
assay
artu
realart
tm
hpacoronaviru
lc
rt
pcr
assay
artu
assay
compar
detect
sarscov
rna
clinic
specimen
ident
parallel
rna
extract
clinic
specimen
use
perform
evalu
assay
sensit
defin
lowest
concentr
sar
viru
detect
time
express
term
limit
detect
lod
assay
sensit
determin
test
serial
dilut
panel
sar
viral
cultur
rna
extract
consist
level
rang
analyz
stratagen
tm
realtim
pcr
system
stratagen
level
dilut
panel
test
total
replic
replic
per
run
run
realtim
pcr
assay
threshold
cycl
defin
cycl
system
begin
detect
increas
signal
associ
exponenti
growth
pcr
product
loglinear
phase
percent
detect
percentag
result
threshold
cycl
ct
valu
less
level
dilut
panel
calcul
percent
detect
fit
log
concentr
use
logist
regress
model
lod
estim
concentr
model
predict
percent
detect
tabl
show
observ
predict
percent
detect
dilut
level
sar
viral
cultur
rna
extract
panel
lod
estim
concentr
predict
detect
fig
base
panel
estim
lod
log
realtim
quantit
rtpcr
assay
mean
ct
valu
invers
proport
log
input
concentr
practic
one
way
assess
linear
assay
plot
mean
ct
valu
log
input
concentr
fit
simpl
linear
regress
assay
linear
establish
regress
plot
slope
close
theoret
valu
assay
precis
reproduc
measur
assay
variabl
repeat
test
replic
ident
input
vari
test
condit
withinrun
betweenrun
replic
assay
precis
commonli
express
term
standard
deviat
sd
coeffici
variat
cv
associ
test
condit
assess
linear
precis
bayer
assay
dilut
panel
made
sar
viral
cultur
rna
construct
test
across
multipl
run
two
oper
three
instrument
viru
panel
consist
level
rang
copi
dilut
level
copi
test
total
replic
replic
per
run
run
dilut
level
copi
test
total
replic
replic
per
run
run
heterolog
amplif
system
serv
intern
control
ad
well
dilut
level
signal
gener
intern
control
increas
confid
realtim
pcr
result
help
elimin
occurr
fals
neg
follow
analys
perform
data
dilut
panel
percent
detect
percentag
result
ct
valu
less
calcul
level
dilut
mean
ct
calcul
dilut
level
base
ct
valu
less
mean
ct
plot
log
nomin
concentr
assess
linear
assay
respons
linear
regress
fit
plot
regress
equat
r
also
calcul
charlen
e
bushdonovan
et
al
linear
mix
model
use
estim
compon
variat
ct
valu
due
betweenrun
withinrun
variabl
base
ct
valu
less
assay
precis
express
term
sd
due
betweenrun
withinrun
total
compon
correspond
cv
also
calcul
total
sd
ct
valu
dilut
panel
plot
nomin
concentr
ct
valu
intern
control
ic
analyz
assess
detect
ic
stabil
ic
signal
rel
concentr
panel
addit
variabl
ct
valu
ic
express
term
total
sd
also
evalu
tabl
show
percent
detect
mean
ct
sd
cv
ct
viral
cultur
rna
extract
panel
figur
show
plot
mean
ct
valu
log
nomin
concentr
viral
cultur
rna
extract
dilut
panel
regress
plot
slope
furthermor
r
valu
shown
plot
indic
linear
regress
fit
data
well
thu
show
highli
linear
respons
assay
figur
show
precis
profil
assay
total
sd
ct
valu
viral
cultur
rna
extract
dilut
panel
plot
log
nomin
concentr
plot
show
precis
fairli
constant
copi
upper
limit
dynam
rang
copi
highest
sd
observ
copi
total
sd
howev
correspond
cv
tabl
show
summari
statist
intern
control
ct
valu
viral
cultur
panel
run
intern
control
detect
well
target
concentr
copi
furthermor
variabl
ct
valu
express
term
total
sd
small
stabl
across
dynam
rang
assay
thu
intern
control
provid
reliabl
signal
assay
process
well
detect
amplif
inhibit
figur
show
plot
mean
ct
ic
nomin
concentr
viral
rna
extract
panel
analyt
specif
assess
test
nucleic
acid
extract
control
panel
common
viral
bacteri
respiratori
pathogen
acquir
american
type
cultur
collect
atcc
manassa
va
usa
clinic
specif
assess
test
nucleic
acid
extract
lung
tissu
nasopharyng
swab
np
whole
blood
lung
deriv
patient
die
sar
outbreak
toronto
sar
defin
cdc
definit
permiss
use
lung
tissu
obtain
chief
coron
offic
ontario
np
swab
nonsar
patient
respiratori
symptom
meet
criteria
sar
permiss
use
sampl
irb
mount
sinai
hospit
univers
health
network
whole
blood
sampl
purchas
sacramento
blood
bank
sacramento
ca
usa
tabl
show
result
specif
studi
bayer
assay
show
high
specif
amplif
signal
nucleic
acid
target
control
panel
sar
neg
clinic
specimen
sampl
store
test
stool
bronchoalveolar
lavag
bal
sampl
collect
clean
steril
contain
np
specimen
collect
use
flexibl
dacrontip
swab
place
viral
transport
media
starplex
scientif
inc
etobicok
canada
tissu
sampl
collect
autopsi
place
steril
contain
snap
frozen
immedi
solut
absolut
ethanol
dri
ice
prior
rna
extract
mucoid
bal
specimen
mix
equal
volum
physiolog
salt
nacl
contain
nacetylcystein
sigmaaldrich
ltd
ontario
canada
incub
min
nonmucoid
bal
specimen
np
specimen
treat
bal
specimen
rna
extract
specimen
use
qiaamp
viral
rna
mini
kit
qiagen
mississauga
canada
one
gram
stool
sampl
mix
ml
distil
rnasefre
water
vortex
allow
settl
room
temperatur
min
vortex
volum
stool
specimen
mix
rneasi
lysi
buffer
rlt
buffer
qiagen
pipet
directli
onto
qiashredd
spin
column
qiagen
place
ml
collect
tube
follow
centrifug
min
supernat
transfer
new
microfug
tube
rna
extract
use
rneasi
mini
kit
qiagen
thirti
milligram
frozen
tissu
deriv
lung
colon
kidney
skelet
muscl
liver
homogen
rlt
buffer
use
dispos
tissu
grinder
kendal
precis
tm
mansfield
usa
homogen
pass
qiashredd
spin
column
done
stool
specimen
rna
extract
use
rneasi
mini
kit
qiagen
extract
rna
frozen
prior
test
postmortem
lung
liver
colon
kidney
skelet
muscl
liver
specimen
well
stool
np
specimen
test
bayer
andor
artu
assay
assess
viral
load
tabl
show
result
compar
two
assay
perform
rna
extract
tissu
tabl
show
result
two
assay
perform
differ
extract
tissu
assay
show
perfect
qualit
agreement
specimen
posit
sarscov
rna
assay
specimen
neg
assay
assay
abl
detect
copi
sarscov
rna
microlit
clinic
sampl
extract
quantit
result
bayer
artu
assay
given
tabl
plot
figur
correl
coeffici
sarscov
rna
concentr
bayer
artu
assay
shown
plot
bayer
result
frequent
quantifi
higher
artu
result
averag
bayer
result
log
fold
higher
artu
assay
higher
viral
load
detect
bayer
assay
may
due
fact
assay
target
nucleocapsid
region
sar
rna
genom
artu
assay
target
polymeras
region
investig
note
pcr
assay
target
nucleocapsid
region
achiev
higher
quantit
valu
assay
target
polymeras
region
sarscov
genom
specul
tissu
subgenom
fragment
contain
nucleocapsid
gene
may
present
contribut
overal
signal
studi
need
investig
mechan
higher
quantif
observ
two
assay
shortli
identif
novel
coronaviru
sarscov
etiolog
agent
sar
number
homebrew
commerci
assay
develop
aid
laboratori
diagnosi
wide
use
assay
continu
either
molecular
amplif
assay
eg
rtpcr
detect
sarscov
rna
clinic
specimen
serolog
assay
detect
specif
sarscov
antibodi
serum
howev
due
urgent
need
laboratori
test
sar
outbreak
mani
assay
put
clinic
use
worldwid
without
undergo
complet
assess
perform
characterist
reflect
cdc
guidelin
laboratori
confirm
sar
infect
caution
assay
remain
investig
result
studi
show
newli
develop
rtpcr
assay
bayer
healthcar
diagnost
perform
extrem
well
detect
sarscov
rna
clinic
specimen
sensit
detect
copi
sarscov
rna
wide
dynam
rang
copi
analyt
clinic
specif
cross
reactiv
common
respiratori
virus
test
clinic
sampl
nonsar
patient
neg
note
howev
accord
cdc
guidelin
one
rule
diagnosi
sar
base
neg
molecular
assay
earli
cours
infect
viral
shed
may
low
detect
mani
assay
well
may
differ
perform
mani
assay
depend
upon
specimen
type
one
first
commerci
avail
pcr
assay
outbreak
realart
hpacoronaviru
lc
rtpcr
assay
artu
artu
bayer
assay
base
realtim
pcr
platform
thu
provid
rel
rapid
result
standard
specimen
process
rna
extract
method
perform
either
artu
bayer
assay
abl
show
assay
highli
correl
qualit
result
posit
neg
artu
bayer
assay
ident
quantit
result
bayer
assay
averag
log
fold
higher
artu
assay
differ
viral
load
quantif
may
due
assay
design
bayer
assay
target
nucleocapsid
region
artu
assay
target
polymeras
region
addit
although
assay
input
volum
target
amplif
reaction
copi
number
bayer
standard
rang
artu
assay
standard
rang
excel
correl
assay
fact
assay
target
differ
genom
region
suggest
use
confirm
posit
result
obtain
fulfil
cdc
requir
laboratori
confirm
case
sar
time
write
known
human
case
sar
anywher
world
despit
potenti
new
case
reappear
remain
avail
properli
valid
sensit
specif
assay
essenti
new
case
accur
diagnos
particularli
light
fact
clinic
definit
suspect
probabl
sar
remain
broad
somewhat
nonspecif
